A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study

Clinical trial NCT02822742 · COMPLETED

Trial details

NCT number: NCT02822742
Sponsor: Santen Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Open Angle Glaucoma or Ocular Hypertension

Start date: 2016-07-02
Primary completion: 2017-04-28
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.